ArticleVaccine2025
An analytic approach considering two temporal mechanisms driving breakthrough viral infections after vaccination.
Article in Vaccine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Real world data is an increasingly utilized resource for post-market monitoring of vaccines and provides insight into real world effectiveness. However, heterogeneous mechanisms may drive observed breakthrough infections among vaccinated individuals, such as waning vaccine-induced immunity or the emergence of a new strain against which the vaccine has reduced protection. Analyses of breakthrough infection incidence rates are typically predicated on a presumed temporal mechanism in their choice of an "analytic time zero" after which infection rates are modeled. In this work, we propose a test that utilizes a standard Cox proportional hazards framework to investigate two temporal mechanisms that can drive breakthrough infections of viral pathogens: waning immunity and the emergence of new strain. We explore the test's performance in simulation studies and in an illustrative application to real world data. We additionally introduce subgroup differences in infection incidence and evaluate the impact of time zero misspecification on bias and coverage of model estimates. In this study we observe strong power and controlled type I error of the test to detect true waning immunity effects under various settings. Similar to previous studies, we find mitigated bias and greater coverage of estimates when the analytic time zero is correctly specified or accounted for.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.